SIM
HZNP

SSI Investment Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

SSI Investment Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-122,950
Closed -$411K – 440
2013
Q3 		$411K Buy
+122,950
New +$324K 0.04% 332

Other funds holding HZNP

MRM
Michael R. Murphy $255M AUM 0.87% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

SSI Investment Management's HZNP Position: Q4 2013 in Review

SSI Investment Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2013, closing a stake of 122,950 shares — an estimated $411K sold.

SSI Investment Management first reported a position in HZNP in Q3 2013 and held it in 1 quarter. The position peaked at $411K in Q3 2013. 95 funds tracked by Wall St. Rank hold HZNP as of Q4 2013.

  • SSI Investment Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2013 after selling out during the quarter.
  • SSI Investment Management sold 122,950 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2013, an estimated $411K.
  • SSI Investment Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2013 and held it in 1 quarter.
  • SSI Investment Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $411K in Q3 2013.
  • 95 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2013.

Based on SSI Investment Management's 13F filing for Q4 2013, filed 7 Feb 2014.